Regeneron Pharmaceuticals has said that it expects to report biomarker data for its Covid-19 antibody cocktail by the end of this month, Reuters reported.
The drugmaker last month struck a partnership with Roche AG to make and supply the Covid-19 antibody cocktail, which is being tested on several hundreds of patients after it prevented and treated the respiratory disease in animals.





























